Adoke Yeka, MPH, MBChB

Assistant Lecturer in the Department of Disease Control and Environmental Health, School of Public Health, College of Health Sciences, Makerere University


E-mail Address:  yadoke@muucsf.org

 

adoke

Current Main Activities:
Researcher, Uganda Malaria Surveillance Project, Kampala, Uganda. Conduct studies on antimalarial drug efficacy, safety and tolerability, compile reports, including statistical and resistance trends, to track the spread of antimalarial drug resistance.

 

Education and Training:
Institute of Public Health, Makerere University, Kampala, Uganda M.P.H (Masters of Public Health) 2001


Makerere University Medical School, Kampala, Uganda. MBChB (Bachelor of Medicine and Surgery) 1994

 

Publications:

1) Van Malderen C, Van Geertruyden JP, Machevo S, González R, Bassat Q, Talisuna A, Yeka A, Nabasumba C, Piola P, Daniel A, Turyakira E, Forret P, Van Overmeir C, van Loen H, Robert A, D' Alessandro U. Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria. Malar J. 2012 Jul 10;11:139. doi: 10.1186/1475-2875-11-139. PMID: 22546009


2) Namagembe A, Ssekabira U, Weaver MR, Blum N, Burnett S, Dorsey G, Sebuyira LM, Ojaku A, Schneider G, Willis K, Yeka A. Improved clinical and laboratory skills after team-based, malaria case management training of health care professionals in Uganda. Malar J. 2012 Feb 13;11:44. doi: 10.1186/1475-2875-11-44. PMID: 22330281


3) Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, Rosenthal PJ, D'Alessandro U. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011 May 24;10:144. doi: 10.1186/1475-2875-10-144. Review. PMID: 21609473


4) Kiggundu M, Nsobya SL, Kamya MR, Filler S, Nasr S, Dorsey G, Yeka A. Evaluation of a comprehensive refresher training program in malaria microscopy covering four districts of Uganda. Am J Trop Med Hyg. 2011 May;84(5):820-4. doi: 10.4269/ajtmh.2011.10-0597. PMID: 21540396


5) Yeka A, Gasasira A, Mpimbaza A, Achan J, Nankabirwa J, Nsobya S, Staedke SG, Donnelly MJ, Wabwire-Mangen F, Talisuna A, Dorsey G, Kamya MR, Rosenthal PJ.Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts. Acta Trop. 2012 Mar;121(3):184-95. doi: 10.1016/j.actatropica.2011.03.004. Epub 2011 Mar 21. Review. PMID: 21420377


6) Ssekabira U, Bukirwa H, Hopkins H, Namagembe A, Weaver MR, Sebuyira LM, Quick L, Staedke S, Yeka A, Kiggundu M, Schneider G, McAdam K, Wabwire-Mangen F, Dorsey G. Improved malaria case management after integrated team-based training of health care workers in Uganda. Am J Trop Med Hyg. 2008 Dec;79(6):826-33. PMID: 19052287


7) Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. Malar J. 2008 Jun 11;7:107. doi: 10.1186/1475-2875-7-107. PMID: 18547416


8) Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One. 2008 Jun 11;3(6):e2390. doi: 10.1371/ journal.pone. 0002390. PMID: 18545692


9) Moses R. Kamya, Adoke Yeka, Hasifa Bukirwa, Myers Lugemwa, John B. Rwakimari, Sarah G. Staedke, Ambrose O. Talisuna, Bryan Greenhouse, Francois Nosten, Philip J. Rosenthal, Fred Wabwire-Mangen, Grant Dorsey: Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial, PLoS Clinical Tials May 2007 e20.


10) Hasifa B, Adoke Y, Moses RK, Ambrose T, Kristin B, Nathan B, John BR, Philip JR, Fred WM, Grant D, Sarah GS. “Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda” PLOS Clinical Trials. 2006 May e7.


11) Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G. “Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.” PLoS Med. 2005 Jul;2(7):e190.


12) Bakyaita N, Dorsey G, Yeka A, Banek K, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya S, Kilian A, Reingold A, Rosenthal PJ, Wabwire-Mangen F. “Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.” Am J Trop Med Hyg. 2005 May;72(5):573-80.


13) Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya S, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G. Artemisinin versus non-artemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Medicine 2005;2(7):e190.


14) Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL, Francis D, Rosenthal PJ, Dorsey G, Havlir D. “Effect of HIV infection on malaria treatment outcomes in Uganda; A population based study.” JID 2006:193:9-15


15) Lee SA, Yeka A, Nsobya SL, Dokomajilar C, Rosenthal PJ, Talisuna A, Dorsey G. “Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at seven sites in Uganda.” J Infect Dis. 2006 Apr 15;193(8):1160-3


16) Francis D, Nsobya SL, Talisuna A, Yeka A, Kamya MR, Machekano R, Dokomajilar C, Rosenthal PJ, Dorsey G. “Geographic differences in antimalarial drug efficacy explained by differences in endemicity and not molecular markers of drug resistance.” J Infect Dis. 2006 Apr 1;193(7):978-86